Inactivators of Ornithine Aminotransferase for the Treatment of Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Inactivators of Ornithine Aminotransferase for the Treatment of Hepatocellular Carcinoma

Published:2021-12-09 Issue:1 Volume:13 Page:38-49
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Silverman Richard B.¹²^ORCID

Affiliation:

1. Department of Chemistry, Department of Molecular Biosciences, Chemistry of Life Processes Institute, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, United States

2. Department of Pharmacology, Chemistry of Life Processes Institute, Feinberg School of Medicine, Chicago, Illinois 60611, United States

Funder

National Cancer Institute

National Institute on Drug Abuse

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.1c00526

Reference80 articles.

1. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. (c) https://www.bluefaery.org/statistics/.

4. https://www.cancer.gov/about-cancer/treatment/types.

5. Management of HCC

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proline Analogues;Chemical Reviews;2024-06-28

2. Synthesis of (2R,4S)-4-Amino-5-hydroxybicyclo[3.1.1]heptane-2-carboxylic Acid via an Asymmetric Intramolecular Mannich Reaction;The Journal of Organic Chemistry;2024-06-10

3. Biomimetic asymmetric transamination reactions catalyzed by axial pyroxamine organocatalysts: Mechanism and origin of stereoselectivity;Molecular Catalysis;2023-10

4. Information-Rich, Dual-Function ¹³C/²H-Isotopic Crosstalk NMR Assay for Human Serine Racemase (hSR) Provides a PLP-Enzyme “Partitioning Fingerprint” and Reveals Disparate Chemotypes for hSR Inhibition;Journal of the American Chemical Society;2023-01-25

5. Advancements in Hepatocellular Carcinoma: Potential Preclinical Drugs and their Future;Current Pharmaceutical Design;2023-01